Utang jangka cendhak marang modal: NEXGEL Inc. (NXGL)

Logo korporat perusahaan NEXGEL, Inc. (NXGL)

NEXGEL, Inc. (NXGL) is developing an advanced environment for creating specialized hydrogels, integrating its unique patches into the supply chains of global brands. The company adheres to environmental standards by minimizing raw material toxicity and purifying industrial emissions. This market valuation chart demonstrates the 0.08 indicator. The business's commercial success relies on regulatory approvals, polymer costs, and the efficiency of partnerships with major pharmacy chains.

NXGL - Koefisien utang jangka cendhak marang modal NEXGEL Inc. ing rentang 04.07.2022 - 30.10.2026
Produk merek NEXGEL

For NEXGEL, Inc. (NXGL), which is scaling the production of innovative hydrogel patches, liquidity control is critical to ensuring uninterrupted technological growth. This indicator is calculated as the ratio of liabilities with a maturity of up to one year to equity; by analyzing the share of short-term loans within the capital, an investor can assess the risk of cash flow gaps and determine the real resilience of the business model to external market shocks.

Pesaing langsung

Utang jangka cendhak marang modal ISRG|DHR - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal BDX (Becton Dickinson & Co)|STE: Rasio utang jangka cendhak marang modal|West Pharmaceutical Services, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Baxter International Inc. BAX|MASI: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Stevanato Group Corp|TFX (Teleflex Incorporated) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal merit.com|Utang jangka cendhak marang ekuitas Envista (NVST)|Utang jangka cendhak marang ekuitas ICUI (ICU Medical Inc)|Dentsply - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal LMAT|AtriCure, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal staar.com STAA|Niagen (NAGE) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal ZIMV|Utang jangka cendhak marang ekuitas AngioDynamics Corp|Cerus Inc (CERS) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas TKNO (Alpha Teknova, Inc.)|Rasio silihan jangka cendhak marang modal MGRM|Utang jangka cendhak marang ekuitas Sharps Technology STSS|Rasio tanggungan utang jangka cendhak marang modal INFU|UTMD: Rasio utang jangka cendhak marang ekuitas|KRMD - Utang jangka cendhak marang modal|Nyxoah S.A. (NYXH) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas microbotmedical.com|PDEX (Pro-Dex) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Zentek Ltd ZTEK|Utang jangka cendhak marang ekuitas Elutia Corp (ELUT)|Milestone Scientific Corporation - Rasio utang jangka cendhak marang modal|Retractable Technologies, Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal HBIO (Harvard Bioscience Inc.)|FEMY - Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal MeihuaMed MHUA|predictive-oncology.com (POAI) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal CJMB|ATRI (Atrion Corporation) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal neurometrix.com NURO